byetta glp-1 diabetes market impact Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Receptor Agonist Market Size

Incorporate balance exercises like single-leg stands or stability ball workouts

10 For instance: The STEP 1 trial , which studied semaglutide (Wegovy) for obesity, used DXA scans (a method to measure body composition) in a subset of participants

However, there is lack of RCTs in T1D using the newest generation of GLP-1RA or dual GLP-1/GIP agonists, which are associated with significantly more weight loss

Economic Implications on Healthcare: The extensive use of GLP-1 drugs might assist in lowering the burden on the healthcare system by potentially reducing the number of complications and comorbidities related to obesity and diabetes, such as heart diseases, kidney issues, and stroke

Read source Gastrointestinal Motility

Ethics declarations Conflict of Interest Robert M